These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8545168)

  • 1. Familial infantile apnea and immature beta oxidation.
    Iafolla AK; Browning IB; Roe CR
    Pediatr Pulmonol; 1995 Sep; 20(3):167-71. PubMed ID: 8545168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
    Harpey JP; Charpentier C; Paturneau-Jouas M
    Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
    Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
    J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sudden infant death syndrome gene: does it exist?
    Opdal SH; Rognum TO
    Pediatrics; 2004 Oct; 114(4):e506-12. PubMed ID: 15466077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial neonatal SIDS revealing carnitine-acylcarnitine translocase deficiency.
    Nuoffer JM; de Lonlay P; Costa C; Roe CR; Chamoles N; Brivet M; Saudubray JM
    Eur J Pediatr; 2000; 159(1-2):82-5. PubMed ID: 10653336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report.
    Thanka J; Padmasani ; Krishnan L; Kuruvilla S
    Indian J Pathol Microbiol; 2005 Oct; 48(4):485-7. PubMed ID: 16366103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercarbic ventilatory responses of infants at risk for SIDS.
    Coleman JM; Mammel MC; Reardon C; Boros SJ
    Pediatr Pulmonol; 1987; 3(4):226-30. PubMed ID: 3658527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and management of fatty acid oxidation defects: a series of 107 patients.
    Saudubray JM; Martin D; de Lonlay P; Touati G; Poggi-Travert F; Bonnet D; Jouvet P; Boutron M; Slama A; Vianey-Saban C; Bonnefont JP; Rabier D; Kamoun P; Brivet M
    J Inherit Metab Dis; 1999 Jun; 22(4):488-502. PubMed ID: 10407781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea in infants: relation to family history of sudden infant death syndrome, apparent life-threatening events, and obstructive sleep apnea.
    McNamara F; Sullivan CE
    J Pediatr; 2000 Mar; 136(3):318-23. PubMed ID: 10700687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immune responses to infections in infants with acute life threatening events classified as 'near-miss' sudden infant death syndrome.
    Gleeson M; Clancy RL; Cox AJ; Gulliver SA; Hall ST; Cooper DM
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):105-18. PubMed ID: 15325403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome.
    Myer EC; Morris DL; Adams ML; Brase DA; Dewey WL
    J Pediatr; 1987 Nov; 111(5):660-6. PubMed ID: 2959762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumograms in infants who subsequently died of sudden infant death syndrome.
    Kelly DH; Golub H; Carley D; Shannon DC
    J Pediatr; 1986 Aug; 109(2):249-54. PubMed ID: 3755468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIDS and disorders of fatty acid oxidation: where do we go from here?
    Cederbaum SD
    J Pediatr; 1998 Jun; 132(6):913-4. PubMed ID: 9627576
    [No Abstract]   [Full Text] [Related]  

  • 20. Why do ALTE infants not die in SIDS?
    Edner A; Wennborg M; Alm B; Lagercrantz H
    Acta Paediatr; 2007 Feb; 96(2):191-4. PubMed ID: 17429903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.